Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
R. Ravichandran. (2010) In Vivo Pharmacokinetic Studies of Albendazole Nanoparticulate Oral Formulations for Improved Bioavailability. International Journal of Green Nanotechnology: Biomedicine 2:1, pages B46-B53.
Read now
Read now
Viktor Cvilink, Jiri Lamka & Lenka Skálová. (2009) Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths. Drug Metabolism Reviews 41:1, pages 8-26.
Read now
Read now
S. Rueda Polo, J. Torrado, F. Bolas & S. Torrado. (1998) A Selective and Simple RP-HPLC Assay To Quantify Albendazole Metabolites in Plasma. Journal of Liquid Chromatography & Related Technologies 21:15, pages 2327-2340.
Read now
Read now
E. Kashiyama, T. Todaka, M. Odomi, Y. Tanokura, D. B. Johnson, T. Yokoi, T. Kamataki & T. Shimizu. (1994) Stereoselective pharmacokinetics and interconversions of flosequinan enantiomers containing chiral sulphoxide in rat. Xenobiotica 24:4, pages 369-377.
Read now
Read now
Carlos E. Lanusse & Roger K. Prichard. (1993) Clinical Pharmacokinetics and Metabolism of Benzimidazole Anthelmintics in Ruminants. Drug Metabolism Reviews 25:3, pages 235-279.
Read now
Read now
Articles from other publishers (68)
Charles Whittaker, Cédric B. Chesnais, Sébastien D. S. Pion, Joseph Kamgno, Martin Walker, Maria-Gloria Basáñez & Michel Boussinesq. (2022) Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis. PLOS Neglected Tropical Diseases 16:10, pages e0010497.
Crossref
Crossref
Cengiz Gokbulut, Veli Y. Cirak, Suleyman Aypak, Hamdi Avci, Selim Sekkin, Hande S. Yalinkilinc, Buket Boga & Erol Ayaz. (2021)
In vivo
exposure of Albendazole sulphoxide by
Haemonchus
contortus
and correlation between plasma and target tissue or gastrointestinal content dispositions in goats
. Journal of Veterinary Pharmacology and Therapeutics 44:5, pages 799-807.
Crossref
Crossref
Regula Theurillat, Guido Stirnimann, Christian Wenker, Stefan Hoby & Wolfgang Thormann. (2021)
Aspects of albendazole metabolism in western lowland gorillas (
Gorilla gorilla gorilla
) compared to humans and other species assessed by HPLC, LC‐MS, and chiral electrokinetic chromatography
. SEPARATION SCIENCE PLUS 4:9, pages 347-356.
Crossref
Crossref
Takanori Takei, Jun Takayama, Meiyan Xuan, Misa Tomoda, Hiroshi Miyamae & Takeshi Sakamoto. (2021) A study of enantioselective syntheses by Sharpless asymmetric oxidation for aryl sulfoxides containing oxygen groups at the ortho position. Journal of Chemical Sciences 133:1.
Crossref
Crossref
G. Vural, M. Yardimci, M. Kocak, T. Ö. Yasar, A. Kurt, I. S. Harem, S. Carradori, I. Sciamanna, M. Siles-Lucas, M. Fabiani, A. Hemphill, B. Lundström-Stadelmann, R. Cirilli & A. Casulli. (2020) Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice. Parasitology 147:13, pages 1425-1432.
Crossref
Crossref
Cengiz Gokbulut & Quintin A. McKellar. (2018) Anthelmintic drugs used in equine species. Veterinary Parasitology 261, pages 27-52.
Crossref
Crossref
Mar Siles-Lucas, Adriano Casulli, Roberto Cirilli & David Carmena. (2018) Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets. PLOS Neglected Tropical Diseases 12:4, pages e0006422.
Crossref
Crossref
Sara da Silva Anacleto, Hanna Leijoto de Oliveira, Anny Talita Maria da Silva, Tienne Aparecida do Nascimento & Keyller Bastos Borges. (2017) Preparation of an organic–inorganic hybrid molecularly imprinted polymer for effective removal of albendazole sulfoxide enantiomers from aqueous medium. Journal of Environmental Chemical Engineering 5:6, pages 6179-6187.
Crossref
Crossref
Lidia Radko, Maria Minta, Piotr Jedziniak & Sylwia Stypuła-Trębas. (2017) Comparison of albendazole cytotoxicity in terms of metabolite formation in four model systems. Journal of Veterinary Research 61:3, pages 313-319.
Crossref
Crossref
Rosella Ferretti, Simone Carradori, Paolo Guglielmi, Marco Pierini, Adriano Casulli & Roberto Cirilli. (2017) Enantiomers of triclabendazole sulfoxide: Analytical and semipreparative HPLC separation, absolute configuration assignment, and transformation into sodium salt. Journal of Pharmaceutical and Biomedical Analysis 140, pages 38-44.
Crossref
Crossref
Roberto Cirilli, Paolo Guglielmi, Francesca Romana Formica, Adriano Casulli & Simone Carradori. (2017) The sodium salt of the enantiomers of ricobendazole: Preparation, solubility and chiroptical properties. Journal of Pharmaceutical and Biomedical Analysis 139, pages 1-7.
Crossref
Crossref
James S. McCarthy & Thomas A. Moore. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
519
527.e3
.
Li Li, Dong-Xu Xing, Qing-Rong Li, Yang Xiao, Ming-Qiang Ye & Qiong Yang. (2014) Determination of Albendazole and Metabolites in Silkworm Bombyx mori Hemolymph by Ultrafast Liquid Chromatography Tandem Triple Quadrupole Mass Spectrometry. PLoS ONE 9:9, pages e105637.
Crossref
Crossref
Kathrin Eckardt, Johanna Kaltenhäuser, Caroline Kilb, Andrea Seiler & Ralf Stahlmann. (2012) Relative potency of albendazole and its sulfoxide metabolite in two in vitro tests for developmental toxicity: The rat whole embryo culture and the mouse embryonic stem cell test. Reproductive Toxicology 34:3, pages 378-384.
Crossref
Crossref
Kátia Roberta A. Belaz, Marina Denadai, Ana Paula Almeida, Raquel T. Lima, M. Helena Vasconcelos, M. Madalena Pinto, Quezia B. Cass & Regina V. Oliveira. (2012) Enantiomeric resolution of albendazole sulfoxide by semipreparative HPLC and in vitro study of growth inhibitory effects on human cancer cell lines. Journal of Pharmaceutical and Biomedical Analysis 66, pages 100-108.
Crossref
Crossref
P. LEES, R. P. HUNTER, P. T. REEVES & P. L. TOUTAIN. (2012) Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination. Journal of Veterinary Pharmacology and Therapeutics 35:s1, pages 17-29.
Crossref
Crossref
Viviane Cangerana Hilário, Daniel Blascke Carrão, Thiago Barth, Keyller Bastos Borges, Niege Araçari Jacometti Cardoso Furtado, Mônica Tallarico Pupo & Anderson Rodrigo Moraes de Oliveira. (2012) Assessment of the stereoselective fungal biotransformation of albendazole and its analysis by HPLC in polar organic mode. Journal of Pharmaceutical and Biomedical Analysis 61, pages 100-107.
Crossref
Crossref
Juan José García-Rodríguez, María Carmen del Vegas-Sánchez, Juan José Torrado-Durán & Francisco Bolás-Fernández. (2011) Enantiomerical pharmacokinetic prevalence of (+) albendazole sulphoxide in Trichinella spiralis muscle larvae. Parasitology Research 110:2, pages 993-999.
Crossref
Crossref
Kuldeep Sharma, Murugesh Kandaswamy, Chandan Mithra, Ashok Kumar Meena, Sanjeev Giri, Sriram Rajagopal & Ramesh Mullangi. (2011) Highly sensitive LC‐MS/MS‐ESI method for simultaneous quantitation of albendazole and ricobendazole in rat plasma and its application to a rat pharmacokinetic study. Biomedical Chromatography 26:2, pages 247-255.
Crossref
Crossref
G. Grogan. 2012. Comprehensive Chirality. Comprehensive Chirality
295
328
.
Daniel B. Carrão, Keyller B. Borges, Thiago Barth, Mônica T. Pupo, Pierina S. Bonato & Anderson R. Moraes de Oliveira. (2011) Capillary electrophoresis and hollow fiber liquid‐phase microextraction for the enantioselective determination of albendazole sulfoxide after biotransformation of albendazole by an endophytic fungus. ELECTROPHORESIS 32:19, pages 2746-2756.
Crossref
Crossref
Moamen S. Refat, Gehad G. Mohamed & Ahmed Fathi. (2011) Spectrophotometric Determination of Albendazole Drug in Tablets: Spectroscopic Characterization of the Charge‐transfer Solid Complexes. Chinese Journal of Chemistry 29:2, pages 324-332.
Crossref
Crossref
G Merino, A J Molina, J L García, M M Pulido, J G Prieto & A I Alvarez. (2003) Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole. Journal of Pharmacy and Pharmacology 55:6, pages 757-764.
Crossref
Crossref
THOMAS A. MOORE. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
631
668
.
J. F. GONZÁLEZ, B. SHAIKH, R. REIMSCHUESSEL & A. S. KANE. (2009)
In vitro
kinetics of hepatic albendazole sulfoxidation in channel catfish (
Ictalurus punctatus
), tilapia (
Oreochromis
sp.), rainbow trout (
Oncorhynchus mykiss
) and induction of EROD activity in ABZ-dosed channel catfish
. Journal of Veterinary Pharmacology and Therapeutics 32:5, pages 429-435.
Crossref
Crossref
Bettencourt P.S. Capece, Guillermo L. Virkel & Carlos E. Lanusse. (2009) Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: Pharmacological implications. The Veterinary Journal 181:3, pages 241-250.
Crossref
Crossref
C. Gokbulut, V.Y. Cirak, B. Senlik, F. Yildirim & Q.A. McKellar. (2009) Pharmacological assessment of netobimin as a potential anthelmintic for use in horses: Plasma disposition, faecal excretion and efficacy. Research in Veterinary Science 86:3, pages 514-520.
Crossref
Crossref
B.P.S. Capece, S.M.S. Afonso, R. Lazáro, M. Harun, C. Godoy, G. Castells & C. Cristòfol. (2009) Effect of age and gender in the pharmacokinetics of albendazole and albendazole sulphoxide enantiomers in goats. Research in Veterinary Science 86:3, pages 498-502.
Crossref
Crossref
V. Cvilink, B. Szotáková, V. Křížová, J. Lamka & L. Skálová. (2009) Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum). Research in Veterinary Science 86:1, pages 49-55.
Crossref
Crossref
C. Gokbulut, A. Bilgili, B. Hanedan & Q.A. McKellar. (2007) Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs. Veterinary Parasitology 148:3-4, pages 279-287.
Crossref
Crossref
C. Gokbulut, V. Y. Cirak & B. Senlik. (2006) Plasma Disposition and Faecal Excretion of Netobimin Metabolites and Enantiospecific Disposition of Albendazole Sulphoxide Produced in Ewes. Veterinary Research Communications 30:7, pages 791-805.
Crossref
Crossref
S. F. SANCHEZ BRUNI, D. G. JONES, J. SMALL & Q. A. MCKELLAR. (2005) Effects of formulation concentration on intravenous pharmacokinetics, chirality and in vitro solubility of oxfendazole and its metabolites in sheep. Journal of Veterinary Pharmacology and Therapeutics 28:5, pages 467-473.
Crossref
Crossref
E. A. Formentini, N. Mestorino & J. O. Errecalde. (2005) Pharmacokinetics of Ricobendazole After its Intravenous, Intraruminal and Subcutaneous Administration in Sheep. Veterinary Research Communications 29:7, pages 595-608.
Crossref
Crossref
J. VELIK, V. BALIHAROVA, L. SKALOVA, B. SZOTAKOVA, V. WSOL & J. LAMKA. (2005) Liver microsomal biotransformation of albendazole in deer, cattle, sheep and pig and some related wild breeds. Journal of Veterinary Pharmacology and Therapeutics 28:4, pages 377-384.
Crossref
Crossref
Zhai Zongde, Luo Xingping, Wu Xiaomei, Zhang Hong, Shi Yanping, Chen Liren & Li Yongmin. (2005) Analytical and semipreparative resolution of enatiomers of albendazole sulfoxide by HPLC on amylose tris (3,5-dimethylphenylcarbamate) chiral stationary phases. Journal of Biochemical and Biophysical Methods 62:1, pages 69-79.
Crossref
Crossref
F. Bolás-Fernández, S. Rama-Iñiguez & J. J. Torrado. (2004) Ex Vivo Anthelmintic Activity of Albendazole-Sulphoxide Enantiomers. Journal of Parasitology 90:2, pages 407-409.
Crossref
Crossref
J Velı́k, V Baliharová, J Fink-Gremmels, S Bull, J Lamka & L Skálová. (2004) Benzimidazole drugs and modulation of biotransformation enzymes. Research in Veterinary Science 76:2, pages 95-108.
Crossref
Crossref
V.L. Lanchote, O.M. Takayanagui & F.H. Mateus. (2004) Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis. Chirality 16:8, pages 520-525.
Crossref
Crossref
J. Velík, V. Baliharová, L. Skálová, B. Szotáková, V. Wsól & J. Lamka. (2003) Stereospecific biotransformation of albendazole in mouflon and rat-isolated hepatocytes. Journal of Veterinary Pharmacology and Therapeutics 26:4, pages 297-302.
Crossref
Crossref
B.P.S. Capece, M. Navarro, T. Arcalis, G. Castells, L. Toribio, F. Perez, A. Carretero, J. Ruberte, M. Arboix & C. Cristòfol. (2003) Albendazole Sulphoxide Enantiomers in Pregnant Rats Embryo Concentrations and Developmental Toxicity. The Veterinary Journal 165:3, pages 266-275.
Crossref
Crossref
A.D Dayan. (2003) Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica 86:2-3, pages 141-159.
Crossref
Crossref
Donald J. AbrahamRobert K. Griffith. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1090
1096
.
Juan José Garcı́a, Francisco Bolás & Juan José Torrado. (2003) Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole. International Journal of Pharmaceutics 250:2, pages 351-358.
Crossref
Crossref
A. Mirfazaelian, M. R. Rouini & S. Dadashzadeh. (2002) Dose dependent pharmacokinetics of albendazole in human. Biopharmaceutics & Drug Disposition 23:9, pages 379-383.
Crossref
Crossref
Francine Prost, Jitka Caslavska & Wolfgang Thormann. (2002) Chiral analysis of albendazole sulfoxide enantiomers in human plasma and saliva using capillary electrophoresis with on-column absorption and fluorescence detection. Journal of Separation Science 25:15-17, pages 1043-1054.
Crossref
Crossref
Dennis Kitzman, Kuei-Ju Cheng & Lawrence Fleckenstein. (2002) HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis 30:3, pages 801-813.
Crossref
Crossref
O. M. Takayanagui, P. S. Bonato, S. A. C. Dreossi & V. L. Lanchote. (2002) Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis. British Journal of Clinical Pharmacology 54:2, pages 125-130.
Crossref
Crossref
Vera L. Lanchote, Fabíola S. Garcia, Sônia A. C. Dreossi & Osvaldo Massaiti Takayanagui. (2002) Pharmacokinetic Interaction Between Albendazole Sulfoxide Enantiomers and Antiepileptic Drugs in Patients With Neurocysticercosis. Therapeutic Drug Monitoring 24:3, pages 338-345.
Crossref
Crossref
B.P.S. Capece, R. Pérez, A. Andaluz, F. Pérez, F. Garcia, G. Castells, M. Arboix & C. Cristòfol. (2002) Placental Transfer of Albendazole Sulphoxide Enantiomers in Sheep. The Veterinary Journal 163:2, pages 155-160.
Crossref
Crossref
M.P. Marques, O.M. Takayanagui & V.L. Lanchote. (2002) Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome P450. Brazilian Journal of Medical and Biological Research 35:2, pages 261-269.
Crossref
Crossref
S. SÁNCHEZ, J. SMALL, D. G. JONES & Q. A. MCKELLAR. (2002) Plasma achiral and chiral pharmacokinetic behaviour of intravenous oxfendazole co‐administered with piperonyl butoxide in sheep. Journal of Veterinary Pharmacology and Therapeutics 25:1, pages 7-13.
Crossref
Crossref
Wolfgang Thormann, Francine Prost & Andrea Procházková. (2002) Capillary electrophoresis with (R)-(−)-N-(3,5-dinitrobenzoyl)-α-phenylglycine as chiral selector for separation of albendazole sulfoxide enantiomers and their analysis in human plasma. Journal of Pharmaceutical and Biomedical Analysis 27:3-4, pages 555-567.
Crossref
Crossref
Mark R. Hadley, Marie Decrette, Gaelle Guilloré, Carlo Rosini, Maria I. Donnoli, Stefano Superchi & Andrew J. Hutt. (2001) Capillary electrophoretic resolution of chiral aryl alkyl and aryl benzyl sulphoxides using sulphatedβ-cyclodextrins as chiral selectors. Journal of Separation Science 24:9, pages 766-776.
Crossref
Crossref
Fernanda O. Paias, Vera L. Lanchote, Osvaldo M. Takayanagui & Pierina Sueli Bonato. (2001) Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis. ELECTROPHORESIS 22:15, pages 3263-3269.
Crossref
Crossref
. 2001. The Physiological Basis of Veterinary Clinical Pharmacology. The Physiological Basis of Veterinary Clinical Pharmacology
136
177
.
G.S. Dow, A.J. O'Hara, S.C. Newton, J.A. Reynoldson & R.C.A. Thompson. (2000) Plasmodium berghei: The Antimalarial Activity of Albendazole in Rats Is Mediated via Effects on the Hematopoietic System. Experimental Parasitology 94:4, pages 259-263.
Crossref
Crossref
Lilián Yépez-Mulia, Raúl Morales-Hurtado, Noemı́ Viveros-Guzmán, Roberto Cedillo-Rivera, Francisco Hernández-Luis, Rafael Castillo, Alicia Hernández-Campos & Onofre Muñoz. (1999) Evaluation of Albendazole Prodrugs in Experimental Trichinellosis. Archives of Medical Research 30:5, pages 368-374.
Crossref
Crossref
Juan José Garcia, Francisco Bolás-Fernández & Juan José Torrado. (1999) Quantitative determination of albendazole and its main metabolites in plasma. Journal of Chromatography B: Biomedical Sciences and Applications 723:1-2, pages 265-271.
Crossref
Crossref
Maria Paula Da Costa Marques, Osvaldo Massaiti Takayanagui, Pierina Sueli Bonato, Silvia Regina Cavani Jorge Santos & Vera Lucia Lanchote. (1999) Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis. Chirality 11:3, pages 218-223.
Crossref
Crossref
A. Slováková, X. Freiin von Maltzan, B. K. Patel, A. F. Drake & A. J. Hutt. (1998) Chromatographic resolution, chiroptical characterization and urinary excretion of the enantiomers of sulindac. Chromatographia 48:5-6, pages 369-376.
Crossref
Crossref
Vera Lucia Lanchote, Maria Paula C Marques, Osvaldo Massaiti Takayanagui, Roberto de Carvalho, Fernanda Orsi Paias & Pierina Sueli Bonato. (1998) Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma. Journal of Chromatography B: Biomedical Sciences and Applications 709:2, pages 273-279.
Crossref
Crossref
Geoffrey S. Dow, James A. Reynoldson & R.C. Andrew Thompson. (1998) Plasmodium berghei: In VivoEfficacy of Albendazole in Different Rodent Models. Experimental Parasitology 88:2, pages 154-156.
Crossref
Crossref
Susana Torrado, M.L López, G Torrado, F Bolás, Santiago Torrado & R Cadórniga. (1997) A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation. International Journal of Pharmaceutics 156:2, pages 181-187.
Crossref
Crossref
Fernanda Orsi Paias, Vera L�cia Lanchote, Osvaldo Massaiti Takayanagui & Pierina Sueli Bonato. (1997) Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase. Chirality 9:8, pages 722-726.
Crossref
Crossref
Francisco Hernández-Luis, Rafael Castillo, Lilian Yépez-Mulia, Roberto Cedillo-Rivera, Gabriel Martínez-Vázquez, Raúl Morales-Hurtado, Helgi Jung, Mónica Sánchez, Alicia Hernández-Campos, Noemí Viveros & Onofre Muñoz. (1996) Preparation of N-methoxycarbonyl-N′-[2-nitro-4(5)-propylthiophenyl]thiourea as prodrugs of albendazole. Bioorganic & Medicinal Chemistry Letters 6:18, pages 2231-2236.
Crossref
Crossref
J. D. BAGGOT & Q. A. McKELLAR. (2008) The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics 17:6, pages 409-419.
Crossref
Crossref
Carlos E. Lanusse & Roger K. Prichard. (1993) Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics. Veterinary Parasitology 49:2-4, pages 123-158.
Crossref
Crossref
Be‐Sheng Kuo, James C. Poole, Arun K. Mandagere & Kin‐Kai Hwang. (2004) Disposition kinetics of ML‐1035 sulfoxide enantiomers and the prochiral sulfide in rats. Chirality 5:6, pages 428-435.
Crossref
Crossref